Lipid signals and insulin resistance

References

• Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76–79 (2003).
   Google Scholar
• Reaven G. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25, 391–406 (2005).
   Google Scholar
• Mikhail N. The metabolic syndrome: insulin resistance. Curr. Hypertens. Rep. 11, 156–158 (2009).
   Google Scholar
• Muoio DM, Newgard C. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in Type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193–205 (2008).
   Google Scholar
• Taubes G. Insulin resistance. Prosperity’s plague. Science 325, 256–260 (2009).
   Google Scholar
• Muoio DM. Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim. Biophys. Acta 1801(3), 281–288 (2010).
   Google Scholar
• Schooneman MG, Vaz FM, Houten SM, Soeters M. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1–8 (2013).
   Google Scholar
• Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 8, 923–934 (2008).
   Google Scholar
• Coen PM, Goodpaster B. Role of intramyocelluar lipids in human health. Trends Endocrinol. Metab. 23, 391–398 (2012).
   Google Scholar
• Jornayvaz FR, Shulman G. Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab. 15, 574–584 (2012).
   Google Scholar
• Savage DB, Petersen KF, Shulman G. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507–520 (2007).
   Google Scholar
• Coleman RA, Mashek D. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem. Rev. 111, 6359–6386 (2011). ▪▪ Comprehensively describes the relationship between lipid metabolism, both lipid synthesis and lipolysis, and insulin signaling transduction.
   Google Scholar
• Nagle CA, An J, Shiota M et al. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J. Biol. Chem. 282, 14807–14815 (2007).
   Google Scholar
• Neschen S, Morino K, Hammond LE et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2, 55–65 (2005). ▪▪ Provides evidence that glycerol-3-phosphate acyltransferase-derived lipid signals impact insulin signaling in the liver and contribute to hepatic insulin resistance.
   Google Scholar
• Nakanaga K, Hama K, Aoki J. Autotaxin – an LPA producing enzyme with diverse functions. J. Biochem. 148, 13–24 (2010).
   Google Scholar
• McIntyre TM, Pontsler AV, Silva AR et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl Acad. Sci. USA 100, 131–136 (2003).
   Google Scholar
• Stapleton CM, Mashek DG, Wang S et al. Lysophosphatidic acid activates peroxisome proliferator activated receptor-gamma in CHO cells that over-express glycerol 3-phosphate acyltransferase-1. PLoS ONE 6, e18932 (2011).
   Google Scholar
• Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med. 331, 1188–1193 (1994).
   Google Scholar
• Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acidmediated mitogenic activation of mTOR signaling. Science 294, 1942–1945 (2001).
   Google Scholar
• Um SH, D’Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3, 393–402 (2006).
   Google Scholar
• Gulati P, Thomas G. Nutrient sensing in the mTOR/S6K1 signalling pathway. BioChem. Soc. Trans. 35, 236–238 (2007).
   Google Scholar
• Loewith R, Jacinto E, Wullschleger S et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457–468 (2002).
   Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini D. Phosphorylation and regulation of Akt/PKB by the rictor–mTOR complex. Science 307, 1098–1101 (2005). ▪▪ Demonstrates that mTORC2 is a key upstream regulator of PKB/Akt, providing an important mechanistic clue that mTORC2 participates in the regulation of insulin signaling transduction.
   Google Scholar
• Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster D. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol. Cell Biol. 29, 1411–1420 (2009).
   Google Scholar
• Shulga YV, Topham MK, Epand R. Regulation and functions of diacylglycerol kinases. Chem. Rev. 111, 6186–6208 (2011).
   Google Scholar
• Merida I, Avila-Flores A, Merino E. Diacylglycerol kinases: at the hub of cell signalling. Biochem. J. 409, 1–18 (2008).
   Google Scholar
• Chibalin AV, Leng Y, Vieira E et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 132, 375–386 (2008).
   Google Scholar
• Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman R. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc. Natl Acad. Sci. USA 109, 1667–1672 (2012). ▪▪ Provides direct evidence that phosphatidic acid, but not diacylglycerol, inhibits insulin signaling in the liver and contributes to hepatic insulin resistance. In addition, the mechanism appears to be that phosphatidic acid, especially that containing 16:0, disrupts mTOR/rictor assembling.
   Google Scholar
• Divecha N, Lander DJ, Scott TW, Irvine R. Molecular species analysis of 1,2-diacylglycerols and phosphatidic acid formed during bombesin stimulation of Swiss 3T3 cells. Biochim. Biophys. Acta 1093, 184–188 (1991).
   Google Scholar
• Lee C, Fisher SK, Agranoff BW, Hajra A. Quantitative analysis of molecular species of diacylglycerol and phosphatidate formed upon muscarinic receptor activation of human SK-N-SH neuroblastoma cells. J. Biol. Chem. 266, 22837–22846 (1991).
   Google Scholar
• Beckman BS, Mallia C, Clejan S. Molecular species of phospholipids in a murine stem-cell line responsive to erythropoietin. Biochem. J. 314(Pt 3), 861–867 (1996).
   Google Scholar
• Pettitt TR, Martin A, Horton T, Liossis C, Lord JM, Wakelam M. Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. Phospholipase D-derived diacylglycerol does not activate protein kinase C in porcine aortic endothelial cells. J. Biol. Chem. 272, 17354–17359 (1997).
   Google Scholar
• Samuel VT, Liu ZX, Wang A et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin Invest. 117, 739–745 (2007).
   Google Scholar
• Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230–50236 (2002).
   Google Scholar
• Samuel VT, Petersen KF, Shulman G. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267–2277 (2010).
   Google Scholar
• Werner ED, Lee J, Hansen L, Yuan M, Shoelson S. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J. Biol. Chem. 279, 35298–35305 (2004).
   Google Scholar
• Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005–2011 (2002).
   Google Scholar
• Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien L. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40, 1397–1403 (1991).
   Google Scholar
• Hoeg LD, Sjoberg KA, Jeppesen J et al. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 60, 64–73 (2010).
   Google Scholar
• Vistisen B, Hellgren LI, Vadset T et al. Effect of gender on lipid-induced insulin resistance in obese subjects. Eur. J. Endocrinol. 158, 61–68 (2008).
   Google Scholar
• Anastasiou CA, Kavouras SA, Lentzas Y, Gova A, Sidossis LS, Melidonis A. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism 58, 1636–1642 (2009).
   Google Scholar
• Perreault L, Bergman BC, Hunerdosse DM, Eckel R. Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes. Obesity (Silver Spring) 18, 2093–2100 (2010).
   Google Scholar
• Amati F, Dube JJ, Alvarez-Carnero E et al. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60, 2588–2597 (2011). ▪▪ Suggests that diacylglycerol is not invariably linked to insulin resistance.
   Google Scholar
• Coen PM, Hames KC, Leachman EM et al. Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity. Obesity (Silver Spring) doi: 10.1002/oby.20381 (2013) (Epub ahead of print). ▪▪ Reviews discrepancies between the widely accepted theories of insulin resistance. Proposes that lipids, endoplasmic reticulum stress, inflammation and mitochondrial dysfunction are not, individually, the sole cause of insulin resistance, but instead, that multiple factors combine to produce insulin resistance.
   Google Scholar
• Timmers S, Nabben M, Bosma M et al. Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proc. Natl Acad. Sci. USA 109, 11711–11716 (2012).
   Google Scholar
• Minehira K, Young SG, Villanueva CJ et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. J. Lipid Res. 49, 2038–2044 (2008).
   Google Scholar
• Monetti M, Levin MC, Watt MJ et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6, 69–78 (2007).
   Google Scholar
• Monetti M, Levin MC, Watt MJ et al. Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proc. Natl Acad. Sci. USA 108, e523; author reply: e524 (2011).
   Google Scholar
• Farese RV Jr, Zechner R, Newgard CB, Walther T. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 15, 570–573 (2012).
   Google Scholar
• Li LO, Klett EL, Coleman R. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta 1801(3), 246–251 (2009).
   Google Scholar
• Soupene E, Kuypers F. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 233, 507–521 (2008).
   Google Scholar
• Chen MT, Kaufman LN, Spennetta T, Shrago E. Effects of high fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41, 564–569 (1992).
   Google Scholar
• Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen E. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46, 1768–1774 (1997).
   Google Scholar
• Ellis BA, Poynten A, Lowy AJ et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279, e554–e560 (2000).
   Google Scholar
• Wright LE, Brandon AE, Hoy AJ et al. Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1beta involves reductions in long-chain acyl-CoA levels and oxidative stress. Diabetologia 54, 1417–1426 (2011).
   Google Scholar
• McGarry J. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes 51, 7–18 (2002).
   Google Scholar
• Koves TR, Ussher JR, Noland RC et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45–56 (2008).
   Google Scholar
• Zhang Y, Li Y, Niepel MW et al. Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance. Proc. Natl Acad. Sci. USA 109, 5417–5422 (2012).
   Google Scholar
• Chavez JA, Summers S. A ceramide-centric view of insulin resistance. Cell Metab. 15, 585–594 (2012).
   Google Scholar
• Cazzolli R, Carpenter L, Biden TJ, Schmitz-Peiffer C. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50, 2210–2218 (2001).
   Google Scholar
• Powell DJ, Hajduch E, Kular G, Hundal H. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol. Cell Biol. 23, 7794–7808 (2003).
   Google Scholar
• Fox TE, Houck KL, O’Neill SM et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J. Biol. Chem. 282, 12450–12457 (2007).
   Google Scholar
• Hajduch E, Turban S, Le Liepvre X et al. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKBdirected signalling by ceramide. Biochem. J. 410, 369–379 (2008).
   Google Scholar
• Holland WL, Bikman BT, Wang LP et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requiressaturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858–1870 (2011).
   Google Scholar
• Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer P. Plasma ceramides are elevated in female children and adolescents with Type 2 diabetes. J. Pediatr. Endocrinol. Metab. 26(9–10), 995–998 (2013).
   Google Scholar
• Holland WL, Brozinick JT, Wang LP et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesityinduced insulin resistance. Cell Metab. 5, 167–179 (2007).
   Google Scholar
• Ussher JR, Koves TR, Cadete VJ et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453–2464 (2010).
   Google Scholar
• Prasad SS, Garg A, Agarwal A. Enzymatic activities of the human AGPAT isoform 3 and isoform 5: localization of AGPAT5 to mitochondria. J. Lipid Res. 52, 451–462 (2010).
   Google Scholar
• Freyberg Z, Sweeney D, Siddhanta A, Bourgoin S, Frohman M, Shields D. Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell 12, 943–955 (2001).
   Google Scholar
• Goto K, Hozumi Y, Nakano T, Saino-Saito S, Martelli A. Lipid messenger, diacylglycerol, and its regulator, diacylglycerol kinase, in cells, organs, and animals: history and perspective. Tohoku J. Exp. Med. 214, 199–212 (2008).
   Google Scholar
• Zhang J, Gao Z, Yin J, Quon MJ, Ye J. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J. Biol. Chem. 283, 35375–35382 (2008).
   Google Scholar
• Rosner M, Hengstschlager M. Detection of cytoplasmic and nuclear functions of mTOR by fractionation. Methods Mol. Biol. 821, 105–124 (2011).
   Google Scholar